Medical News

RSS

FDA grants Haemonetics clearance to collect two RBC on Cymbal system

On January 27, 2010 the FDA cleared the Haemonetics 510(k) for its expanded nomogram to collect two Red Blood Cells on the Cymbal® Automated Blood Collection System from female donors who are at least 150 pounds and are 63 inches in height. The Cymbal is a small, portable, battery operated instrument that automates blood collection from volunteer donors, improving process control and helping alleviate blood shortages.

23 Feb 2010

HSA Bank reports 7.6% increase in average balance carried into 2010

HSA Bank reported today that the average Health Savings Account (HSA) balance carried into 2010 grew by 7.6 percent over the balance carried into 2009. The average balance of these accounts grew even though the nation faced the uncertainty of a recovering global economy, ailing retirement accounts, unemployment and healthcare reform.

23 Feb 2010

Public option again gains steam; Cadillac tax would fall equally on non-union plans

The public option is gaining steam again, while a new study on the "Cadillac tax" suggests it would fall equally on union and non-union health plans.

23 Feb 2010

Orszag says health reform 'absolutely' still possible; Enzi's posture offers evidence of partisan stalemate

News outlets report on some of the major figures in the health care overhaul debate, including Peter Orszag, director of the White House Office of Management and Budget, and Sen. Mike Enzi, R-Wyo.

23 Feb 2010

DURECT, Nycomed amend POSIDUR Development and License Agreement

DURECT Corporation announced today that Nycomed and DURECT have amended the Development and License Agreement entered into between the parties in 2006 covering the development and commercialization of POSIDUR™ (also known as SABER™-Bupivacaine or OPTESIA™), an investigational drug for the treatment of post-surgical pain.

23 Feb 2010

Healthcare Realty Trust reports increased revenues and net earnings for 2009 fourth quarter

Healthcare Realty Trust Incorporated today announced results for the fourth quarter ended December 31, 2009. Funds from operations ("FFO," as defined by the National Association of Real Estate Investment Trusts, "NAREIT") per diluted common share for the three months ended December 31, 2009 totaled $0.35, compared with $0.49 for the three months ended December 31, 2008.

23 Feb 2010

Star Scientific seeks FDA marketing approval for Ariva-BDL dissolvable tobacco lozenge

Star Scientific, Inc. announced that on Friday, February 19 the company filed an application with the Food & Drug Administration for approval to market Ariva-BDL™ as a "modified risk" tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009. This submission is the first such application to be filed with the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.

23 Feb 2010

MRI: An efficient diagnostic tool for testicular cancer

Researchers have found that non-invasive magnetic resonance imaging (MRI) is a good diagnostic tool for the evaluation and staging of testicular cancer and may improve patient care by sparing some men unnecessary surgery, according to a study in the March issue of the American Journal of Roentgenology.

23 Feb 2010

Eon Labs to pay $3.5M for resolving False Claims Act allegations concerning Nitroglycerin SR capsules

Eon Labs Inc. has agreed to pay the United States $3.5 million to resolve False Claims Act allegations relating to the company's drug Nitroglycerin Sustained Release (SR) capsules, the Justice Department announced today. Eon Labs is a subsidiary of Sando Inc., which is in turn a subsidiary of Novartis AG.

23 Feb 2010

Nursing workforce issues: An expanded role for nurse practitioners, Calif. doctors sue for supervision of nurse anesthetists

News outlets report on nursing workforce issues, including a push for an expanded role for nurse practitioners, supervision of nurse anesthetists and a trend toward delayed retirement.

23 Feb 2010

CINJ researchers test malaria drug for colorectal cancer treatment

While new cases of colorectal cancer continue to decline in the United States, it remains the third leading cause of cancer death in the nation, according to the American Cancer Society. That is why researchers at The Cancer Institute of New Jersey are looking to add a drug known for fighting malaria to traditional chemotherapy for colorectal cancer to see if treatment can be made more effective for patients.

23 Feb 2010

Gene study provides new clues to fight infections

Investigators at The Methodist Hospital Research Institute in Houston examined for the first time the long-term response to strep throat on a genome-wide level, shedding light on how group A streptococcus interacts with the patient's immune system and attempts to circumvent it.

23 Feb 2010

Medicaid cuts hurt Calif. dental coverage, drive away doctors in Okla; Public hospitals in NYC fear possible reductions

NPR: "In California, it's been seven months since some 3 million poor and disabled adults lost their dental coverage to budget cuts. ... While the recession may be easing, California and other states across the country continue to face eye-popping budget deficits. As a result, states are cutting deep into public health programs, and dental benefits for Medicaid recipients top the list. ... Before the state budget cuts, Medicaid patients here could get annual exams, cleanings and, if needed, root canals to save their teeth.

23 Feb 2010

Medical test for aging adults could be helpful in determining infants’ intestinal conditions

A medical test initially researched for aging adults also could be helpful for premature babies, according to scientists with Texas AgriLife Research.

23 Feb 2010

UCI researchers create new breed of flightless mosquitoes for dengue control

UCI researchers and colleagues from Oxitec Ltd. and the University of Oxford created the new breed. Flightless females are expected to die quickly in the wild, curtailing the number of mosquitoes and reducing - or even eliminating - dengue transmission. Males of the strain can fly but do not bite or convey disease.

23 Feb 2010

Study shows hospitals costs vary widely and are not associated with quality of care

The costs that hospitals incur in treating patients vary widely and do not appear to be strongly associated either with the quality of care patients receive or their risk of dying within 30 days, according to a report in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 Feb 2010

Cancer Institute awards MCRA designation to Cooper University Hospital

Enhancing its collective strength in the area of oncology research in the state, The Cancer Institute of New Jersey has announced that Cooper University Hospital will be the fourth affiliate hospital within its Network to receive the prestigious Major Clinical Research Affiliate designation.

23 Feb 2010

Merrimack Pharmaceuticals commences dosing in MM-121/Tarceva combination Phase 1/2 study for NSCLC

Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva® (erlotinib) in patients with non-small cell lung cancer (NSCLC). This is the first of multiple trials that Merrimack and sanofi-aventis expect to initiate in 2010 as part of a broad Phase 2 clinical development program for MM-121.

23 Feb 2010

Agilent Technologies wins breach of contract case against Advanced Materials Technology

Agilent Technologies Inc. today announced a favorable decision in its trade secrets and breach of contract case against Advanced Materials Technology, Inc. (AMT) and three of its employees in the Delaware Court of Chancery. Agilent filed the lawsuit in January 2008 to protect confidential and proprietary information relating to its high-performance liquid chromatography technology.

23 Feb 2010

Global rules barring TB patients from flying are too stringent, study says

A "controversial" study, released on Sunday, "suggests international rules that bar potentially infectious tuberculosis patients from flying are too stringent and airline passengers are really at little risk from catching TB from a fellow traveler," the Associated Press/Washington Post reports. The paper is being published in the March edition of Lancet Infectious Diseases (Stobbe, 2/21).

23 Feb 2010

Medical News

FDA grants Haemonetics clearance to collect two RBC on Cymbal system

HSA Bank reports 7.6% increase in average balance carried into 2010

Public option again gains steam; Cadillac tax would fall equally on non-union plans

Orszag says health reform 'absolutely' still possible; Enzi's posture offers evidence of partisan stalemate

DURECT, Nycomed amend POSIDUR Development and License Agreement

Healthcare Realty Trust reports increased revenues and net earnings for 2009 fourth quarter

Star Scientific seeks FDA marketing approval for Ariva-BDL dissolvable tobacco lozenge

MRI: An efficient diagnostic tool for testicular cancer

Eon Labs to pay $3.5M for resolving False Claims Act allegations concerning Nitroglycerin SR capsules

Nursing workforce issues: An expanded role for nurse practitioners, Calif. doctors sue for supervision of nurse anesthetists

CINJ researchers test malaria drug for colorectal cancer treatment

Gene study provides new clues to fight infections

Medicaid cuts hurt Calif. dental coverage, drive away doctors in Okla; Public hospitals in NYC fear possible reductions

Medical test for aging adults could be helpful in determining infants’ intestinal conditions

UCI researchers create new breed of flightless mosquitoes for dengue control

Study shows hospitals costs vary widely and are not associated with quality of care

Cancer Institute awards MCRA designation to Cooper University Hospital

Merrimack Pharmaceuticals commences dosing in MM-121/Tarceva combination Phase 1/2 study for NSCLC

Agilent Technologies wins breach of contract case against Advanced Materials Technology

Global rules barring TB patients from flying are too stringent, study says

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News